NIH researchers working on tissue chips for better disease modelling

Tissue chips to enable successful drug development

Emily Event News Leave a Comment

With the high levels of uncertainty when working on live animals and human models, it is unsurprising that approximately 30 percent of promising medications fail in human clinical trials because of their pharmacovigilance properties. Thus, eliminating adverse effects at the earlier stage of drug development process will save costs and time for sponsor companies investing in the research, enabling researchers …